Chong Kun Dang Pharmaceutical
Clinical trials sponsored by Chong Kun Dang Pharmaceutical, explained in plain language.
-
New study aims to find safer diabetes combo treatment
Disease control Not yet recruitingThis study tests two different drugs, empagliflozin and glimepiride, added to current diabetes treatment in 200 adults with type 2 diabetes. The goal is to see which combination better controls blood sugar without causing low blood sugar or weight gain. Participants will take the…
Phase: PHASE4 • Sponsor: Chong Kun Dang Pharmaceutical • Aim: Disease control
Last updated May 01, 2026 15:59 UTC
-
New drug cocktail CKD-215 tested in ovarian cancer patients
Disease control Not yet recruitingThis early-stage study compares two drug formulations (CKD-215 and D215) in 24 adults with advanced BRCA-mutated ovarian, fallopian tube, or primary peritoneal cancer. The goal is to see how the body processes each drug and check for side effects. Participants will receive both t…
Phase: PHASE1 • Sponsor: Chong Kun Dang Pharmaceutical • Aim: Disease control
Last updated May 01, 2026 15:58 UTC